Roanoke-based Chorda Pharma moves toward product release with grant Gene Marrano June 27, 2022 1 minute read Chorda Pharma, a local pharmaceutical company looking to bring its first product, Capsadyn – an over the counter medication for chronic pain to market next year – has received an important grant from the Commonwealth Commercialization Fund. Share: Post navigation Previous: Congressman Bob Good pushes Life at Conception ActNext: Late on returning library books? That’s no longer a problem Related Stories Calling all heroes: TAP asks for donations for its Superhero Kids Counseling Program Emma Thomas April 23, 2026 Roanoke Fashion Week Returns Emma Thomas April 22, 2026 Virginia redistricting referendum passes by razor-thin margin as legal challenges loom Ian Price April 22, 2026